Head of Unit
University Hospital of Salamanca
Salamanca, Castilla y Leon, Spain
Dr. María-Victoria Mateos, MD, PhD, is Head of Myeloma and clinical trials Unit at the Haematology Department and Professor of Medicine at the University of Salamanca, Spain.
She serves as coordinator of GEM (Spanish Myeloma Group), with direct involvement in the design and development of clinical trials. She has coordinated many clinical trials especially in the setting of transplant ineligible and smouldering myeloma and these trials have profoundly influenced current options for the management of these patient populations.
She has published over 350 papers in international journals with a H index of 96 and 74 since 2015.
She is also a member of the IMWG (International MM Working Group), IMS (International MM Society), EHA and ASH.
She has served on the ASH Scientific Committee on plasma cell diseases between 2015-2019 and on the EHA’s Scientific Program Committee and Advisory Board since 2013 until 2020 being chair of the Scientific Program Committee in 2019.
She has been Councillor on the EHA Board since 2015 for a four-year mandate and she remains as member of the IMS executive board, member of the European School of Haematology (ESH) Scientific committee and member of the ASCO scientific program committee during 2022 and 2023. She received the Briand Durie Award in 2019 and the Bart Barlogie Award in 2022 recognizing excellence in myeloma research. She is the President of the National Society of Hematology since October 2022 for a four-year mandate.
Newly Diagnosed Multiple Myeloma
Wednesday, September 27, 2023
3:30 PM – 5:30 PM EEST